Skip to main content
. Author manuscript; available in PMC: 2018 Mar 8.
Published in final edited form as: Nucl Med Biol. 2013 Sep 24;40(8):994–999. doi: 10.1016/j.nucmedbio.2013.08.005

Figure 3.

Figure 3

SUV in each tumor was determined and presented as the percentage of the SUV prior to treatment in each mouse. The first week SUVs before treatment were considered to be 100%. Post-treatment SUVs (3rd week, 5th week and 7th week) were expressed as a percentage of the 1st week pretreatment SUV for comparison.